Hosted on MSN

Standard BioTools outlines $165M-$175M revenue target for FY2025 while driving proteomics partnerships

CEO Michael Egholm highlighted that Standard BioTools delivered Q1 2025 revenues of $40.8 million, aligned with their plan despite a challenging operating backdrop. He emphasized improvements in ...
Business Insider

Standard BioTools Reports Third Quarter 2025 Financial Results

SOUTH SAN FRANCISCO, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) (the “Company” or “Standard BioTools”) today announced financial results for the quarter ended ...